1,080.36
price up icon0.53%   5.68
after-market Dopo l'orario di chiusura: 1078.00 -2.36 -0.22%
loading

Lilly Eli Co Borsa (LLY) Ultime notizie

pulisher
10:03 AM

Eli Lilly & Co.: How a 150-Year-Old Pharma Giant Became the World’s Hottest Growth Product - AD HOC NEWS

10:03 AM
pulisher
11:24 AM

Pfizer: Why Wall Street Gave Up—And Why That May Be a Mistake - Investing.com

11:24 AM
pulisher
10:01 AM

Behind the Scenes of Eli Lilly's Latest Options Trends - Benzinga

10:01 AM
pulisher
09:01 AM

Institutional Investors Signal Confidence in Eli Lilly Amidst Market Crosscurrents - AD HOC NEWS

09:01 AM
pulisher
08:00 AM

What Makes Eli Lilly And Co. (LLY) a Worthy Holding? - Insider Monkey

08:00 AM
pulisher
05:58 AM

RVW Wealth LLC Invests $910,000 in Eli Lilly and Company $LLY - MarketBeat

05:58 AM
pulisher
05:44 AM

Miracle Mile Advisors LLC Grows Stock Position in Eli Lilly and Company $LLY - MarketBeat

05:44 AM
pulisher
03:52 AM

Celltrion completes acquisition of US Eli Lilly plant - theinvestor.co.kr

03:52 AM
pulisher
03:52 AM

Burns J W & Co. Inc. NY Has $3.35 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat

03:52 AM
pulisher
02:54 AM

Celltrion Acquires Eli Lilly’s U.S. Facility with 680 billion won CMO Contract - Businesskorea

02:54 AM
pulisher
Jan 01, 2026

The Truth About Eli Lilly and Company: Why Everyone Is Betting Big On This Pharma Giant - AD HOC NEWS

Jan 01, 2026
pulisher
Jan 01, 2026

Celltrion completes acquisition of Eli Lilly manufacturing facility in New Jersey - koreabiomed.com

Jan 01, 2026
pulisher
Jan 01, 2026

Eli Lilly stock forecast 2026: Analysts see modest upside as pricing pressure bites - ts2.tech

Jan 01, 2026
pulisher
Jan 01, 2026

Eli Lilly stock ends 2025 lower as 2026 drug-price shifts and GLP-1 pill race come into focus - ts2.tech

Jan 01, 2026
pulisher
Jan 01, 2026

Smith Salley Wealth Management Has $14.84 Million Stake in Eli Lilly and Company $LLY - MarketBeat

Jan 01, 2026
pulisher
Jan 01, 2026

Eli Lilly and Company $LLY Stake Decreased by Calamos Advisors LLC - MarketBeat

Jan 01, 2026
pulisher
Jan 01, 2026

Ayrshire Capital Management LLC Has $7.42 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat

Jan 01, 2026
pulisher
Jan 01, 2026

Eli Lilly’s Strategic Gamble: Deep Price Cuts in China Challenge Profit Outlook - AD HOC NEWS

Jan 01, 2026
pulisher
Dec 31, 2025

Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026 - ts2.tech

Dec 31, 2025
pulisher
Dec 31, 2025

Could This Potential Move Boost Eli Lilly's Prospects? - AOL.com

Dec 31, 2025
pulisher
Dec 31, 2025

Triangle biotech backed by Eli Lilly files to go public - The Business Journals

Dec 31, 2025
pulisher
Dec 31, 2025

Segment Wealth Management LLC Buys 10,042 Shares of Eli Lilly and Company $LLY - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Simplify Asset Management Inc. Sells 4,453 Shares of Eli Lilly and Company $LLY - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Mirova US LLC Has $290.45 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Eli Lilly’s Strategic Pivot: A Price War in China for Market Dominance - AD HOC NEWS

Dec 31, 2025
pulisher
Dec 30, 2025

Eli Lilly Engages in Strategic Price Competition Amid Record Valuation - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly-backed Insilico eyes beyond pharma with new AI models - Nikkei Asia

Dec 30, 2025
pulisher
Dec 30, 2025

Why Is Vanda Pharmaceuticals' (VNDA) Stock Trending Overnight? - Benzinga

Dec 30, 2025
pulisher
Dec 30, 2025

AI Company Raises 2.3 Billion Yuan for Listing with Eli Lilly and Temasek's Backing - 36Kr

Dec 30, 2025
pulisher
Dec 30, 2025

The Truth About Eli Lilly and Company: Why Everyone on Wall Street Is Obsessed Right Now - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly (LLY) Moves Fast to Secure Lead in India's Obesity Drug Market - Finviz

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly (LLY) Moves Fast to Secure Lead in India’s Obesity Drug Market - Yahoo Finance

Dec 30, 2025
pulisher
Dec 30, 2025

Novo and Lilly cut prices of weight-loss drugs in China - Reuters

Dec 30, 2025
pulisher
Dec 30, 2025

Lilly Endowment Sells 3,593 Shares of Eli Lilly & Co - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly and Novo Nordisk Shares Dip After Cut Obesity Drug Prices in China - GuruFocus

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly’s Strategic Price Cut Intensifies Rivalry in Chinese Weight-Loss Market - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China - Yahoo Finance UK

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly & Co.: How a 150-Year-Old Giant Became the Hottest Product Story in Pharma - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly (LLY) and Novo Nordisk (NVO) Slash GLP-1 Drug Prices i - GuruFocus

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly, Novo waging price wars as obesity drug market heats up in China - Seeking Alpha

Dec 30, 2025
pulisher
Dec 30, 2025

Price war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro - Medical Dialogues

Dec 30, 2025
pulisher
Dec 30, 2025

Total Wealth Planning LLC Grows Stock Holdings in Eli Lilly and Company $LLY - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Sapient Capital LLC Purchases 259,392 Shares of Eli Lilly and Company $LLY - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Novo Nordisk, Eli Lilly cut obesity drug prices in China - Investing.com

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly stock: juggernaut at all?time highs tests how much optimism is too much - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Eli Lilly And Co (LLY) Stock Price Today - CoinMarketCap

Dec 30, 2025
pulisher
Dec 30, 2025

Novo Nordisk, Eli Lilly cut obesity drug prices in China By Investing.com - Investing.com Australia

Dec 30, 2025
pulisher
Dec 30, 2025

Novo Nordisk, Eli Lilly Reportedly Cut Prices of Weight Loss Drugs in CN Mkt - AASTOCKS.com

Dec 30, 2025
pulisher
Dec 29, 2025

As global obesity treatments such as Eli Lilly's "Munzaro" and Novo Nordisk's "Wigobi" have gained w.. - 매일경제

Dec 29, 2025
pulisher
Dec 29, 2025

Eli Lilly’s Strategic Position Holds Firm Amid Novo Nordisk’s Oral Weight-Loss Drug Approval - AD HOC NEWS

Dec 29, 2025
pulisher
Dec 29, 2025

Eli Lilly and Company Limited - Lifespan.io

Dec 29, 2025
pulisher
Dec 29, 2025

Major Eli Lilly Insider Quietly Unloads More Shares in Multi-Million Dollar Move - TipRanks

Dec 29, 2025
pulisher
Dec 29, 2025

With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market - statnews.com

Dec 29, 2025
pulisher
Dec 29, 2025

Eli Lilly, Space Command top economic stories in Huntsville in 2025 - AL.com

Dec 29, 2025
pulisher
Dec 29, 2025

Eli Lilly (LLY) and Novo Nordisk (NVO) May Benefit from New Medi - GuruFocus

Dec 29, 2025
pulisher
Dec 29, 2025

Eli Lilly Stock Near Record Highs: Can The Weight-Loss King Keep Defying Gravity? - AD HOC NEWS

Dec 29, 2025
pulisher
Dec 29, 2025

Kempner Capital Management Inc. Acquires New Position in Eli Lilly and Company $LLY - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Apollon Wealth Management LLC Purchases 4,298 Shares of Eli Lilly and Company $LLY - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Eli Lilly Shares Navigate a Complex Landscape of Catalysts and Competition - AD HOC NEWS

Dec 29, 2025
pulisher
Dec 28, 2025

Eli Lilly Stock (LLY) News Today: What Investors Should Watch Before Monday’s Open After GLP‑1 Pill Breakthroughs, Pricing Signals, and Fresh Deal Headlines - ts2.tech

Dec 28, 2025
pulisher
Dec 28, 2025

Why Eli Lilly’s Mounjaro Is Reshaping Obesity Care — and the LLY Stock Story Behind It - AD HOC NEWS

Dec 28, 2025
pulisher
Dec 28, 2025

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026 - 24/7 Wall St.

Dec 28, 2025
pulisher
Dec 28, 2025

Eli Lilly and Company $LLY Holdings Decreased by Nvwm LLC - MarketBeat

Dec 28, 2025
drug_manufacturers_general JNJ
$207.35
price up icon 0.19%
$229.31
price up icon 0.36%
drug_manufacturers_general NVS
$138.54
price up icon 0.49%
drug_manufacturers_general MRK
$106.45
price up icon 1.13%
drug_manufacturers_general NVO
$52.39
price up icon 2.97%
Capitalizzazione:     |  Volume (24 ore):